TP53 and neoplasm: Eight of these mutations (R175, V157F, Y220C, G245, R248, R249, R273 and R282) account for ~28% of total mutations in TP53 with R5, R248 and R273 being reported in multiple tumor types, suggesting that there is a selection for these mutant alleles in cancer [22].